4-[4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl]-2-methylthieno[2,3-b][1,5]benzoxazepine

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-[4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl]-2-methylthieno[2,3-b][1,5]benzoxazepine
• 英文别名: 2-[2-[4-(2-Methylthieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl]ethoxy]ethanol
• 化学式: C₂₀H₂₅N₃O₃S
• 分子量: 387.503
• InChiKey: IMMPOJOTKDPBEM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  27
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  85.8
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  1-[2-(2-羟基乙氧基)乙基]哌嗪 、 2-methylthieno[2,3-b][1,5]benzoxazepin-4(5H)-one 以 氯仿 、 N,N-二甲基苯胺 、 甲苯 为溶剂， 生成 4-[4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl]-2-methylthieno[2,3-b][1,5]benzoxazepine
  参考文献：
  名称：

  Fused thiophene compounds and medicinal use thereof

  摘要：

  公式（I）的一种缩合噻吩化合物，其中每个符号如规范中定义，其药学上可接受的盐及水合物。本发明的公式（I）化合物可用作一种新型抗精神病药物，对精神分裂症的阳性症状和阴性症状均有效，与较少的副作用（如外周性运动障碍等）相关，并且与严重副作用（如粒细胞缺乏症等）的关联较小。此外，该化合物还可用作治疗阿尔茨海默病和躁郁症的药物。

  公开号：

  US06271225B1

文献信息

• FUSED THIOPHENE COMPOUNDS AND MEDICINAL USE THEREOF
  申请人：YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD.

  公开号：EP1016664A1

  公开（公告）日：2000-07-05

  A condensed thiophene compound of the formula (I) wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof and hydrates thereof. The compound of the formula (I) of the present invention is useful as a novel antipsychotic agent which is effective for both positive symptoms and negative symptoms of schizophrenia, which is associated with less side effects such as extrapyramidal motor disorder and the like and which is less associated with serious side effects such as agranulocytosis and the like. In addition, this compound is also useful as a therapeutic agent of Alzheimer's disease and manic-depressive illness.

  式 (I) 的缩合噻吩化合物 其中各符号如说明书中所定义，其药学上可接受的盐及其水合物。本发明的式(I)化合物可作为一种新型抗精神病药物，对精神分裂症的阳性症状和阴性症状均有效，副作用较少，如锥体外系运动障碍等，严重副作用较少，如粒细胞减少等。此外，该化合物还可用作阿尔茨海默病和躁狂抑郁症的治疗剂。
• US6271225B1
  申请人：——

  公开号：US6271225B1

  公开（公告）日：2001-08-07
• US6455521B1
  申请人：——

  公开号：US6455521B1

  公开（公告）日：2002-09-24
• Fused thiophene compounds and medicinal use thereof
  申请人：Welfide Corporation

  公开号：US06271225B1

  公开（公告）日：2001-08-07

  A condensed thiophene compound of the formula (I) wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof and hydrates thereof. The compound of the formula (I) of the present invention is useful as a novel antipsychotic agent which is effective for both positive symptoms and negative symptoms of schizophrenia, which is associated with less side effects such as extrapyramidal motor disorder and the like and which is less associated with serious side effects such as agranulocytosis and the like. In addition, this compound is also useful as a therapeutic agent of Alzheimer's disease and manic-depressive illness.

  公式（I）的一种缩合噻吩化合物，其中每个符号如规范中定义，其药学上可接受的盐及水合物。本发明的公式（I）化合物可用作一种新型抗精神病药物，对精神分裂症的阳性症状和阴性症状均有效，与较少的副作用（如外周性运动障碍等）相关，并且与严重副作用（如粒细胞缺乏症等）的关联较小。此外，该化合物还可用作治疗阿尔茨海默病和躁郁症的药物。